JAK2 and acute myeloid leukemia: In our study, the incidence of JAK2 V617F mutation was not similar to other publications differing in the occurrence of V617F mutation in AML, ALL cases (Peeters et al., 1997).This observation opens new avenues for fundamental and clinical researches and has direct implications for the diagnosis .